Detalhe da pesquisa
1.
A multimodal atlas of hepatocellular carcinoma reveals convergent evolutionary paths and 'bad apple' effect on clinical trajectory.
J Hepatol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782118
2.
Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma.
BMC Cancer
; 23(1): 118, 2023 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36737737
3.
A genomic enhancer signature associates with hepatocellular carcinoma prognosis.
JHEP Rep
; 5(6): 100715, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37168287
4.
Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study.
Natl Sci Rev
; 9(3): nwab192, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35382356
5.
PD-L1 protein expression and copy number gains in HIV-positive locally advanced cervical cancer.
Ther Adv Med Oncol
; 12: 1758835920963001, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33149767
6.
Impact of antiretroviral drugs on PD-L1 expression and copy number gains with clinical outcomes in HIV-positive and -negative locally advanced cervical cancers.
Oncol Lett
; 18(6): 5747-5758, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31788048